Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient Dalteparin for DVT in Low Risk Cancer Patients
NCT00041782Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2000
- Primary completion
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dalteparin in deep vein thrombosis (DVT), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2000; status: terminated.
02
Drugs
dalteparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00041782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041782.